CRH and CRH-related peptides (e.g., urocotins), as well as specific receptors, have been detected in several tumor tissues, serving as a rational basis not only to hypothesize that CRH may be involved in cellular proliferation, migration, invasion, and apoptosis but also offering potential pharmacological targets. The gene discussed is CRH; the disease is neoplasm.